![Charles Flynn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Flynn
Direttore/Membro del Consiglio presso SynDevRx, Inc.
Posizioni attive di Charles Flynn
Società | Posizione | Inizio | Fine |
---|---|---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Charles Flynn
Formazione di Charles Flynn
Yale University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Settori
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Charles Flynn
- Esperienza